Taat CW - Search Results

1

Intermittent continuous infusion of ifosfamide and 5-fluorouracil in patients with advanced adenocarcinoma of the pancreas.

Poorter RL, Bakker PJ, Huizing MT, Taat CW, Rietbroek RC, Gouma DJ, Rauws EA, Veenhof CH. Poorter RL, et al. Among authors: taat cw. Ann Oncol. 1995 Dec;6(10):1048-9. doi: 10.1093/oxfordjournals.annonc.a059070. Ann Oncol. 1995. PMID: 8750159 Free article.

2

Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: relationship between plasma concentrations and clinical parameters.

Poorter RL, Peters GJ, Bakker PJ, Taat CW, Biermans-van Leeuwe DM, Codacci-Pisanelli G, Noordhuis P, Oosting J, Veenhof CH. Poorter RL, et al. Among authors: taat cw. Eur J Cancer. 1995;31A(9):1465-70. doi: 10.1016/0959-8049(95)00217-7. Eur J Cancer. 1995. PMID: 7577073

3

Intermittent continuous infusion of 5-fluorouracil in combination with epirubicin and cisplatin in advanced gastric cancer: the importance of dose intensity.

Poorter RL, Bakker PJ, Fockens P, Taat CW, Bartelsman JF, Veenhof CH. Poorter RL, et al. Among authors: taat cw. J Infus Chemother. 1996 Spring;6(2):87-91. J Infus Chemother. 1996. PMID: 8809656 Clinical Trial.

4

Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy.

Poorter RL, Lauw FN, Bemelman WA, Bakker PJ, Taat CW, Veenhof CH. Poorter RL, et al. Among authors: taat cw. Eur J Cancer. 1996 Dec;32A(13):2262-6. doi: 10.1016/s0959-8049(96)00274-2. Eur J Cancer. 1996. PMID: 9038608

5

Epirubicin, cisplatin and intermittent continuous infusion of 5-fluorouracil in advanced gastric cancer: an effective regimen?

Poorter RL, Bakker PJ, Taat CW, Bartelsman JF, Veenhof CH. Poorter RL, et al. Among authors: taat cw. Eur J Cancer. 1994;30A(9):1404. doi: 10.1016/0959-8049(94)90198-8. Eur J Cancer. 1994. PMID: 7999436 Clinical Trial. No abstract available.

6

Intermittent continuous intravenous infusion of 5-fluorouracil; a useful approach in disseminated colorectal cancer?

Poorter RL, Bakker PJ, Taat CW, Veenhof CH. Poorter RL, et al. Among authors: taat cw. Eur J Cancer. 1993;29A(5):775. doi: 10.1016/s0959-8049(05)80366-1. Eur J Cancer. 1993. PMID: 8471339 No abstract available.

7

Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE.

Rijks LJ, Bakker PJ, van Tienhoven G, Noorduyn LA, Boer GJ, Rietbroek RC, Taat CW, Janssen AG, Veenhof CH, van Royen EA. Rijks LJ, et al. Among authors: taat cw. J Clin Oncol. 1997 Jul;15(7):2536-45. doi: 10.1200/JCO.1997.15.7.2536. J Clin Oncol. 1997. PMID: 9215822

8

Leiomyosarcoma of large and small veins: clinical findings and results of treatment in six patients.

van Gulik TM, Taat CW, Slors JF, Bras J, Blank LE, Bakker PJ, Kromhout JG, Brummelkamp WH. van Gulik TM, et al. Among authors: taat cw. Eur J Surg Oncol. 1991 Apr;17(2):125-34. Eur J Surg Oncol. 1991. PMID: 2015919

9

Role of extended lymph node dissection in the treatment of gastrointestinal tumours: a review of the literature.

Taat CW, van Laschot JJ, Gouma DJ, Obertop H. Taat CW, et al. Scand J Gastroenterol Suppl. 1995;212:109-16. doi: 10.3109/00365529509090309. Scand J Gastroenterol Suppl. 1995. PMID: 8578223 Review.

10

Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients.

Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW, et al. Bonenkamp JJ, et al. Among authors: taat cw. Lancet. 1995 Mar 25;345(8952):745-8. doi: 10.1016/s0140-6736(95)90637-1. Lancet. 1995. PMID: 7891484 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters